Global histone modifications as markers of pancreatic ductal adenocarcinoma prognosis

被引：0
|
作者：
Lu, Y. [1 ]
Kim, L. [1 ]
Frederick, B. [1 ]
Zhang, M. [1 ]
Liao, J. [1 ]
Talamonti, M. [1 ]
Bentrem, D. [1 ]
Rao, S. M. [1 ]
Yang, G. Y. [1 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
来源：
LABORATORY INVESTIGATION | 2008年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1413
引用
收藏
页码：310A / 310A
页数：1
相关论文
共 50 条
  • [31] Tumor buds determine prognosis in resected pancreatic ductal adenocarcinoma
    Juhling, A.
    Sinn, M.
    Klein, F.
    Bischoff, S.
    Striefler, J. K.
    Pelzer, U.
    Oettle, H.
    Riess, H.
    Denkert, C.
    Blaker, H.
    Lohneis, P.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 191 - 191
  • [32] The role of miRNAs in the diagnosis, chemoresistance, and prognosis of pancreatic ductal adenocarcinoma
    Ren, Le
    Yu, Yue
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2018, 14 : 179 - 187
  • [33] Clinical impact of sarcopenia on prognosis in pancreatic ductal adenocarcinoma.
    Ninomiya, Go
    Fujii, Tsutomu
    Yamada, Suguru
    Asano, Tomonari
    Takano, Nao
    Takami, Hideki
    Iwata, Naoki
    Kanda, Mitsuro
    Niwa, Yukiko
    Hayashi, Masamichi
    Kobayashi, Daisuke
    Tanaka, Chie
    Nakayama, Goro
    Sugimoto, Hiroyuki
    Fujiwara, Michitaka
    Koike, Masahiko
    Kodera, Yasuhiro
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [34] The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma
    Tascilar, M
    Skinner, HG
    Rosty, C
    Sohn, T
    Wilentz, RE
    Offerhaus, GJA
    Adsay, V
    Abrams, RA
    Cameron, JL
    Kern, SE
    Yeo, CJ
    Hruban, RH
    Goggins, M
    CLINICAL CANCER RESEARCH, 2001, 7 (12) : 4115 - 4121
  • [35] Tumour buds determine prognosis in resected pancreatic ductal adenocarcinoma
    Philipp Lohneis
    Marianne Sinn
    Fritz Klein
    Sven Bischoff
    Jana K. Striefler
    Lilianna Wislocka
    Bruno V. Sinn
    Uwe Pelzer
    Helmut Oettle
    Hanno Riess
    Carsten Denkert
    Hendrik Bläker
    Anja Jühling
    British Journal of Cancer, 2018, 118 : 1485 - 1491
  • [36] Arpin downregulation is associated with poor prognosis in pancreatic ductal adenocarcinoma
    Zhang, Shi-Rong
    Li, Hao
    Wang, Wen-Quan
    Jin, Wei
    Xu, Jin-Zhi
    Xu, Hua-Xiang
    Wu, Chun-Tao
    Gao, He-Li
    Li, Shuo
    Li, Tian-Jiao
    Zhang, Wu-Hu
    Xu, Shuai-Shuai
    Ni, Quan-Xing
    Yu, Xian-Jun
    Liu, Lang
    EJSO, 2019, 45 (05): : 769 - 775
  • [37] Tumour buds determine prognosis in resected pancreatic ductal adenocarcinoma
    Lohneis, Philipp
    Sinn, Marianne
    Klein, Fritz
    Bischoff, Sven
    Striefler, Jana K.
    Wislocka, Lilianna
    Sinn, Bruno V.
    Pelzer, Uwe
    Oettle, Helmut
    Riess, Hanno
    Denkert, Carsten
    Blaeker, Hendrik
    Juehling, Anja
    BRITISH JOURNAL OF CANCER, 2018, 118 (11) : 1485 - 1491
  • [38] The Role of Inflammatory Markers in Predicting Resectability of Pancreatic Ductal Adenocarcinoma
    Agalianos, Christos
    Gouvas, Nikolaos
    Manatakis, Dimitrios K.
    Sideris, Ioannis
    Passas, Ioannis
    Dervenis, Christos
    CHIRURGIA, 2022, 117 (04) : 431 - 436
  • [39] Epithelial-mesenchymal transition markers in pancreatic ductal adenocarcinoma
    Black, C. C.
    Byrd, R. H.
    Fohn, L. E.
    Totsas, A. D.
    Washington, M. K.
    Cates, J. M.
    LABORATORY INVESTIGATION, 2008, 88 : 113A - 113A
  • [40] Epithelial-mesenchymal transition markers in pancreatic ductal adenocarcinoma
    Black, C. C.
    Byrd, R. H.
    Fohn, L. E.
    Tatsas, A. D.
    Washington, M. K.
    Cates, J. M.
    MODERN PATHOLOGY, 2008, 21 : 113A - 113A
12345